Penpulimab Injection
NDC 83654-105
Product Information
Penpulimab is a BLA-approved product labeled by Akeso Biopharma, Co., Ltd. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a injection for intravenous administration. This product entry covers the primary NDC 83654-105 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 83654-105?
What are the uses of this product?
What are Active Ingredients of this product?
- PENPULIMAB 100 mg/10mL - humanised anti-programmed cell death 1 (PD-1) monoclonal antibody
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- PENPULIMAB (UNII: IBS1BZ4E4I)
- PENPULIMAB (UNII: IBS1BZ4E4I) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ACETIC ACID (UNII: Q40Q9N063P)
- SORBITOL (UNII: 506T60A25R)
- SODIUM ACETATE (UNII: 4550K0SC9B)
- POLYSORBATE 80 (UNII: 6OZP39ZG8H)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 2712652 - penpulimab-kcqx 100 MG in 10 ML Injection
- RxCUI: 2712652 - 10 ML penpulimab-kcqx 10 MG/ML Injection
- RxCUI: 2712652 - penpulimab-kcqx 100 MG per 10 ML Injection
* Please review the full disclaimer at the bottom of this page.